The Latest Cardiac and Vascular News
Feb. 1, 2018 19:16 UTC –ClearFlow spokespeople cite review article as latest piece of mounting evidence pertaining to urgent need for managing retained blood after surgery– ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, a medical device company based in Anaheim, CA., has announced that […]
IRVINE, Calif., Jan. 11, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest® Investigational Device Exemption (IDE) Trial. The study […]
ST. LOUIS, March 14, 2017 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported results of a study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France, which […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it has named Dr. David B. DeLurgio as the national principal investigator (PI) for the CONVERGE […]
